Home > Insider Trading > Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals Inc. (REGN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
101 - 110
Next >>

Hedge Funds Have Never Been More Bullish On Regeneron Pharmaceuticals Inc (REGN)

Coronavirus is probably the #1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW.

Keep Reading →

March 12th, 2020 - Hedge Funds News

2019 Review: Most Favored Hedge Fund Stocks vs. Regeneron Pharmaceuticals Inc (REGN)

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.

Keep Reading →

December 26th, 2019 - Hedge Funds News

Did Hedge Funds Drop The Ball On Regeneron Pharmaceuticals Inc (REGN) ?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Keep Reading →

December 4th, 2019 - Hedge Funds News

Hedge Funds Have Never Been This Bullish On Regeneron Pharmaceuticals Inc (REGN)

Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million...

Keep Reading →

October 10th, 2019 - Hedge Funds News

Here's What Hedge Funds Think About Regeneron Pharmaceuticals Inc (REGN)

Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would...

Keep Reading →

June 14th, 2019 - Hedge Funds News

Is Regeneron Pharmaceuticals Inc (REGN) A Good Stock To Buy?

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December 31.

Keep Reading →

March 28th, 2019 - Hedge Funds News

Hedge Funds Are Crazy About Regeneron Pharmaceuticals Inc (REGN)

Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.

Keep Reading →

December 11th, 2018 - Hedge Funds News